Gateway 2011: GE Analytical Instruments - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2011: GE Analytical Instruments



Your online Gateway to GE Analytical Instruments in 2011

6060 Spine Road
Boulder, CO 80301
303-444-2009/ 800 255-6964
www.geinstruments.com

About GE Analytical Instruments

InnovOx Lab & On-Line Wastewater TOC Analyzers

GE Analytical Instruments, a division of GE Water & Process Technologies, is dedicated to providing state-of-the-art instruments for simpler, faster, and more accurate analytical measurement of contaminants in water. The global leader in instruments used to measure total organic carbon (TOC) in water, GE Analytical Instruments is known for its technical innovations and holds over 30 patents. GE Analytical Instruments is ISO 9001-2008 registered. Sievers is the leading global TOC analyzer brand for pharmaceutical applications, with thousands of installations worldwide. Sievers TOC laboratory, on-line and portable analyzers are known for their unsurpassed analytical performance and ease of use.

Sievers Family Ultrapure Water TOC Analyzers

 

New Products
and Releases

TOC Buyer's Guide Overview

News & Upcoming Events
Pharma/Biopharmaceutical Overview

 

For more information:

geai@ge.com

 

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns

Click here